Compare PTGX & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | GMED |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 11.0B |
| IPO Year | 2016 | 2012 |
| Metric | PTGX | GMED |
|---|---|---|
| Price | $150.62 | $83.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $108.23 | $100.42 |
| AVG Volume (30 Days) | 456.0K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | ★ 2.35 | 2.00 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $874.25 | $11.13 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | $64.08 | ★ $41.48 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $57.45 | $54.17 |
| 52 Week High | $160.81 | $101.40 |
| Indicator | PTGX | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 48.59 |
| Support Level | $94.48 | $74.52 |
| Resistance Level | $160.81 | $87.55 |
| Average True Range (ATR) | 5.13 | 2.60 |
| MACD | -0.92 | -0.36 |
| Stochastic Oscillator | 25.63 | 23.04 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.